| Serial Number | 88476968 |
| Word Mark | LITE SWITCH |
| Filing Date | Monday, June 17, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, January 9, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 14, 2020 |
| Pseudo Mark | LIGHT SWITCH |
| Goods and Services | Medical and pharmaceutical research services; pharmaceutical research and development; pharmaceutical research and development related to the prevention or treatment of disease with substances that stimulate the immune response; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research, namely, conducting clinical trials for others; laboratory research services relating to pharmaceuticals; scientific and technological services, namely, research and design services in the field of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological services consultation services in the field of development, manufacturing and testing of pharmaceuticals and biopharmaceuticals; providing product research and development in the pharmaceutical field for purposes of process development, validation, qualification, and manufacturing of pharmaceuticals and biopharmaceuticals; scientific and technological consultation services in the field of pharmaceutical research and pharmacology; custom development of pharmaceutical, biopharmaceutical and chemical products; providing evaluation testing for pharmaceutical, biopharmaceutical and chemical products, and medical devices featuring testing for safety, toxicity, content, identity, purity, configuration and function, using chemical, in vitro or in vivo assays, analyses and models; pre-clinical and non-clinical evaluation testing of pharmaceutical, biopharmaceutical and chemical products performed primarily using animals and other biological models; pharmaceutical, biopharmaceutical, and chemical research and development for others; pharmaceutical research in the field of immunotherapy; pharmaceutical research for the treatment of infectious, deficiency, hereditary, and physiological diseases |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, June 27, 2019 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Soteria Biotherapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94107 |
| Party Name | Soteria Biotherapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94107 |
| Event Date | Event Description |
| Monday, January 9, 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, January 9, 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, April 8, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, April 6, 2022 | SOU EXTENSION 4 GRANTED |
| Wednesday, April 6, 2022 | SOU EXTENSION 4 FILED |
| Wednesday, April 6, 2022 | TEAS EXTENSION RECEIVED |
| Saturday, November 13, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, November 11, 2021 | SOU EXTENSION 3 GRANTED |
| Thursday, November 11, 2021 | SOU EXTENSION 3 FILED |
| Thursday, November 11, 2021 | TEAS EXTENSION RECEIVED |
| Thursday, April 15, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 13, 2021 | SOU EXTENSION 2 GRANTED |
| Tuesday, April 13, 2021 | SOU EXTENSION 2 FILED |
| Tuesday, April 13, 2021 | TEAS EXTENSION RECEIVED |
| Thursday, July 23, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 21, 2020 | SOU EXTENSION 1 GRANTED |
| Tuesday, July 21, 2020 | SOU EXTENSION 1 FILED |
| Tuesday, July 21, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, June 9, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 14, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 14, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 25, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, March 19, 2020 | REVIEW OF CORRESPONDENCE COMPLETE |
| Friday, March 6, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, March 7, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Saturday, March 7, 2020 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, March 7, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, March 7, 2020 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, March 7, 2020 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, September 9, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, September 9, 2019 | NON-FINAL ACTION WRITTEN |
| Sunday, September 8, 2019 | ASSIGNED TO EXAMINER |
| Thursday, June 27, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Thursday, June 20, 2019 | NEW APPLICATION ENTERED IN TRAM |